Abridge company profile: valuation, funding & revenue

This Abridge company profile covers the company's valuation, revenue, funding rounds, investors and history. Abridge works in health technology, with a focus on AI clinical documentation. It was founded in 2018 and is headquartered in Pittsburgh, Pennsylvania, United States. Its latest valuation on record is US$5.3 billion (2025). Every figure links to a public source, and anything the company hasn't disclosed is marked as such.

Revenue

Funding history

Abridge timeline

Key dates from the sources on this page, oldest first. Metric snapshots are listed after the funding events.

• 2018 — Abridge is founded in Pittsburgh by Shiv Rao (CEO) and Sandeep Konam.
• Feb 2025 — Series D: US$250M, valuing the company at US$2.75B.
• 2025 — Series E: US$300M, valuing the company at US$5.3B. Investors: Andreessen Horowitz (lead); Khosla Ventures.

Investors

Overview

Abridge makes AI software that listens to conversations between clinicians and patients, with the patient's consent, and turns them into structured clinical notes. Instead of typing into the electronic health record during or after each visit, a doctor can focus on the patient while Abridge drafts the note, which the doctor then reviews and signs. The company has become one of the leading "ambient AI" documentation providers to large US health systems.

Shiv Rao, a practising cardiologist, founded Abridge in Pittsburgh in 2018 with Sandeep Konam, a machine learning engineer. Rao had experienced first-hand how much of a physician's day goes to documentation, often late into the evening, a major cause of burnout. Abridge built its early models with researchers from Carnegie Mellon University and spent years refining them before generative AI made the category explode.

The problem it solves

Studies of US physicians have found that they spend roughly as much time on the electronic health record as with patients, and much of that work spills into evenings, which doctors call "pajama time". Documentation requirements for billing, compliance and care coordination have grown steadily. That burden contributes to burnout, early retirement and staffing shortages. A tool that reliably cuts documentation time can improve clinicians' working lives and let them see more patients, which matters to health systems facing workforce shortages.

How the product works

• Capture: the clinician starts a recording on a phone or computer during the visit, after the patient agrees.
• Drafting: Abridge's models transcribe the conversation and produce a draft note in the right format for the specialty, organised into sections such as history, assessment and plan.
• Evidence linking: each part of the note links back to the moment in the conversation it came from, so the clinician can verify it quickly. Abridge calls this "linked evidence".
• Integration: the note flows into the health record system, most importantly Epic, which many large US hospitals use. Abridge was one of the first partners in Epic's programme for ambient documentation.
• Beyond notes: the company has expanded into areas such as coding support, patient summaries in plain language, and real-time prompts during visits.

Business model

Abridge sells enterprise contracts to health systems, typically priced per clinician, and rolls out across departments and specialties. Its customers include large academic medical centres and regional health systems. Because hospitals buy at system level and expand over time, a single contract can grow to thousands of clinicians. Abridge doesn't publish revenue; analyst estimates have put annual recurring revenue above US$100 million, but we show revenue as not disclosed.

Funding

• February 2025, Series D: US$250 million at a valuation of about US$2.75 billion.
• 2025, Series E: US$300 million at US$5.3 billion, led by Andreessen Horowitz with Khosla Ventures participating, roughly doubling its value in months.

Some coverage in 2026 described a further extension at the same US$5.3 billion valuation. Earlier investors include Lightspeed, Redpoint, Spark Capital and CVS Health Ventures. Total funding is reported at around US$800 million, though sources differ.

Competition

The ambient documentation market has become crowded. Abridge's main competitors include Microsoft's Nuance, whose DAX Copilot is integrated into Microsoft's healthcare offering, Ambience Healthcare, Suki, Nabla and many smaller startups. Epic itself has announced ambient documentation features, which could compete directly with partners. Abridge's advantages are its early health system relationships, its evidence-linking approach and its specialty coverage. Medical AI search tools such as OpenEvidence serve a different need, answering clinical questions rather than writing notes.

Abridge at a glance

Abridge is a Pittsburgh health AI company founded in 2018 by cardiologist Shiv Rao and Sandeep Konam. Its ambient AI turns clinician-patient conversations into clinical notes inside the health record. It raised US$250 million at about US$2.75 billion in February 2025 and US$300 million at US$5.3 billion later that year, led by Andreessen Horowitz.

Measuring the value of AI documentation

Health systems evaluate ambient AI on several measures: time spent on notes per visit, after-hours work, clinician satisfaction and burnout scores, note quality and accuracy, and financial effects such as better coding or more appointments per day. Early studies and health system reports have shown meaningful reductions in documentation time and improvements in clinicians' experience, though results vary by specialty and by how well the tool is adopted. The financial case is strongest when time saved translates into more patient visits or reduced staff turnover.

Risks and safeguards

Using AI in clinical documentation raises genuine concerns. A note containing an error, such as a wrong medication dose or a symptom the patient didn't mention, could affect future care. That's why clinicians must review every note and why traceability back to the source conversation matters. Patient consent and privacy are essential, and recordings must be handled under US health privacy law. Health systems also need to consider whether AI-generated notes change billing patterns in ways insurers or regulators might question.

Questions health systems ask vendors

• How accurate are notes in our specialties, and how are errors measured?
• How deeply does it integrate with our health record system?
• Where are recordings stored, for how long, and who can access them?
• What results have similar health systems seen on time saved and clinician satisfaction?

Why Epic integration matters so much

In large US hospitals, the electronic health record is the centre of daily work, and Epic is the most widely used system among big health systems. A documentation tool that sits outside the record forces clinicians to copy and paste, which wastes the time the tool is meant to save. Deep integration lets the AI draft go straight into the right fields, pull in relevant patient history and fit into existing workflows on phones and desktops. Abridge's early position in Epic's partner programme gave it an advantage in large deals. The flip side is dependence: if the record vendor builds a strong native feature, partners must keep proving they are better.

Latest developments (October 2026)

Abridge's last priced round remains its June 2025 Series E, which valued the company at about US$5.3 billion. Secondary-market estimates published in 2026 put its implied value higher, at roughly US$6 billion to US$7 billion, but these are trader estimates rather than company-confirmed rounds, so we continue to show the priced figure. Demand for ambient clinical documentation kept growing through 2026 as health systems expanded deployments beyond pilots, and Abridge competes with Microsoft's Nuance, Ambience Healthcare and electronic health record vendors adding their own scribe tools. Our healthcare AI guide tracks the segment.

Where it goes from here

Key developments to watch include revenue disclosures, expansion to nurses and other care teams, international growth, competition from Epic's own tools and Microsoft, and any new funding round or IPO preparation.

Who should care

Health system leaders can use ambient AI to address burnout, but should measure results carefully. Clinicians should treat AI notes as drafts that require review. Investors should weigh fast adoption against intensifying competition and the risk that the health record vendors build similar features themselves.

Sources

Every figure on this page comes from the public sources below. Where sources disagreed, we used the company's own announcement or a primary news report. Private-company data changes; check the date beside each figure.

1. MobiHealthNews